Allegra wilde ny

Evidence that an individual has tampered with a drug or alcohol test during employee’s employment with the District. Information that an allegra wilde ny employee has caused, contributed to, or been involved in an accident while at work. The occurrence of an accident, while at work or working, in and of itself shall not constitute reasonable suspicion.

However, individual circumstances of an accident, including, but not limited to, the nature and extent of the employee’s involvement in the accident, may be considered as one element of reasonable suspicion. Evidence that an employee has used, possessed, sold, solicited, or transferred drugs while working or while on District premises or while operating District vehicles, machinery or equipment. If testing is conducted based on reasonable suspicion, the District will immediately document the circumstances that formed the basis of determination to warrant the testing. The original documentation shall be kept confidential by the District pursuant to this policy and shall be retained for at least one (1) year. A copy of this documentation shall be given to the employee upon written request. Follow-up - If an employee, in the course of employment, has a confirmed positive drug or alcohol test and allegra wilde ny subsequently accesses the Employee Assistance Program (EAP) for drug-related and/or alcohol-related problems or enters an alcohol and drug rehabilitation program, allegra wilde ny the District will require the employee to submit to a drug and/or allegra wilde ny alcohol test upon completion of the program as follow-up to such program, and on a quarterly basis, for two (2) years thereafter. DRUG TESTING PROCEDURE All specimen collection and testing for drugs shall be allegra wilde ny conducted in accordance with Sections 440.

The District may test for any or all of the following: Alcohol Amphetamines Cannabinoids Cocaine Phencyclidine Methaqualone Opiates Barbiturates Benzodiazepines Methadone Propoxyphene 2. The initial screen for all drugs shall use an immunoassay. The initial test for alcohol shall be an enzyme oxidation methodology. When first allegra wilde ny screening specimens, all levels equal to or allegra wilde ny exceeding the following shall be reported as positive: Alcohol . 05g% (by blood) Amphetamines 1000 ng/ml Cannabinoids 50 ng/ml Cocaine 300 ng/ml Phencyclidine 25 ng/ml Methaqualone 300 ng/ml allegra wilde ny Opiates 300 ng/ml Barbiturates 300 ng/ml Benzodiazepines 300 ng/ml allegra wilde ny Methadone 300 ng/ml Propoxyphene 300 ng/ml These levels will allegra wilde ny remain in effect until such time as they are revised by Federal allegra wilde ny Legislation or State Statute. All new allegra wilde ny levels will become effective on the date specified within the related legislation. All specimens identified as positive on the initial tests shall be confirmed using a second test. A gas chromatography/mass spectrometry (GC/MS) allegra wilde ny test, or an equivalent or more accurate scientifically accepted method approved by the allegra wilde ny State or Federal government will be allegra wilde ny used for the confirmation test for narcotics. The confirmation test for alcohol will be gas chromatography.

All confirmations shall be done by quantitative analysis. When confirming initial results, all levels equal to or exceeding the following shall be reported as positive: Alcohol john allegro wiki . 05g% (by blood) Amphetamines 500 ng/ml Cannabinoids 15 allegra wilde ny ng/ml Cocaine 150 ng/ml Phencyclidine 25 ng/ml Methaqualone 150 ng/ml Opiates 300 ng/ml Barbiturates 150 ng/ml Benzodiazepines 150 ng/ml Methadone 150 ng/ml Propoxyphene 150 ng/ml These levels will remain in effect until such time as they are revised by Federal Legislation or State Statute. All new levels will become effective on the date specified within the related legislation.

The laboratory shall report test results to a medical review officer (MRO) chosen by the District to act on its behalf.